(Q35827475)

10 August 2017

1 reference

title

The ARIA/EAACI criteria for antihistamines: an assessment of the efficacy, safety and pharmacology of desloratadine (English)

1 reference

10 August 2017

1 reference

Carsten Bindslev-Jensen

2

object named as

Bindslev-Jensen C

1 reference

10 August 2017

6

Kowalski M

1 reference

10 August 2017

Bousquet J

1

1 reference

10 August 2017

Canonica GW

3

1 reference

10 August 2017

Fokkens W

4

1 reference

10 August 2017

Kim H

5

1 reference

10 August 2017

Magnan A

7

1 reference

10 August 2017

Mullol J

8

1 reference

10 August 2017

van Cauwenberge P

9

1 reference

10 August 2017

publication date

1 January 2004

1 reference

10 August 2017

1 reference

10 August 2017

volume

59 Suppl 77

1 reference

10 August 2017

page(s)

4-16

1 reference

Biochemical characterization of desloratadine, a potent antagonist of the human histamine H(1) receptor

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2004.00577.X

Anticholinergic effects of desloratadine, the major metabolite of loratadine, in rabbit and guinea-pig iris smooth muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2004.00577.X

Inhibition of cytokine secretion from human leukemic mast cells and basophils by H1- and H2-receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2004.00577.X

Constitutive activity of the histamine H(1) receptor reveals inverse agonism of histamine H(1) receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2004.00577.X

H1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2004.00577.X

Effect of desloratadine and loratadine on rhinovirus-induced intercellular adhesion molecule 1 upregulation and promoter activation in respiratory epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2004.00577.X

Pharmacokinetic and safety profile of desloratadine and fexofenadine when coadministered with azithromycin: a randomized, placebo-controlled, parallel-group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2004.00577.X

Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2004.00577.X

The effects of fruit juices on drug disposition: a new model for drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2004.00577.X

24-hour efficacy of once-daily desloratadine therapy in patients with seasonal allergic rhinitis [ISRCTN32042139]

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2004.00577.X

Comparative Effects of Desloratadine versus Montelukast on Asthma Symptoms and Use of β<sub>2</sub>-Agonists in Patients with Seasonal Allergic Rhinitis and Asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2004.00577.X

Efficacy and safety of desloratadine in the treatment of perennial allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2004.00577.X

Desloratadine reduces nasal congestion in patients with intermittent allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2004.00577.X

Comparison of the effects of desloratadine 5-mg daily and placebo on nasal airflow and seasonal allergic rhinitis symptoms induced by grass pollen exposure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2004.00577.X

Effect of desloratadine versus placebo on nasal airflow and subjective measures of nasal obstruction in subjects with grass pollen-induced allergic rhinitis in an allergen-exposure unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2004.00577.X

Pregnancy outcome after gestational exposure to loratadine or antihistamines: a prospective controlled cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2004.00577.X

Fetal safety of loratadine use in the first trimester of pregnancy: a multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2004.00577.X

Efficacy and safety of desloratadine 5 mg once daily in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2004.00577.X

Once-daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2004.00577.X

10.1111/J.1398-9995.2004.00577.X

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference